October 31, 2017 / 8:31 PM / a month ago

BRIEF-Aduro Biotech reports Q3 loss per share $0.33

Oct 31 (Reuters) - Aduro Biotech Inc:

* Aduro Biotech reports third quarter 2017 financial results

* Q3 loss per share $0.33

* Q3 revenue $3.8 million versus $3.8 million

* Q3 revenue view $6.1 million -- Thomson Reuters I/B/E/S

* Q3 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S

* Aduro Biotech Inc - ‍ anticipated 2017 milestones include to initiate phase 1 multiple myeloma trial with bion-1301, an anti-April antibody​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below